Published in Blood Weekly, April 22nd, 2004
According to recent research from Germany, "This prospective study assessed the impact of FDG-PET scanning on the staging and possible consequential changes of treatment regimen in patients with Hodgkin lymphoma (HL).
"A total of 88 consecutive patients with histologically verified Hodgkin lymphoma underwent a PET scan in addition to conventional staging procedures. Treatment was based on the conventional staging only, and the results of the FDG-PET did not affect the treatment strategy," wrote...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.